Summit Therapeutics, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US86627T1088
USD
13.96
0.42 (3.1%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summarySummit Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
1D
3.1%
0.62%
1W
7.22%
3.58%
1M
-12.09%
3.38%
YTD
-20.18%
13.32%
1Y
-50.27%
22.36%
3Y
684.27%
71.69%
5Y
76.49%
74.86%
10Y
98.04%
255.39%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-18.6%
0%
-18.6%
6 Months
-6.87%
0%
-6.87%
1 Year
-50.27%
0%
-50.27%
2 Years
48.51%
0%
48.51%
3 Years
684.27%
0%
684.27%
4 Years
1466.6%
0%
1466.6%
5 Years
76.49%
0%
76.49%

Summit Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary